Form D · Biotechnology
PROGENITY, INC.
San Diego, CA · CIK 0001580063
Offering snapshot reported Apr 27, 2020 · SEC filing
- Reported sold
- $10M Offering amount: $60M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 3, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 27, 2020 | Amendment | $9,999,999 | $0vs Apr 20, 2020 | 1 | SEC filing |
| Apr 20, 2020 | Initial | $9,999,999 | No comparison | 1 | SEC filing |
| Nov 27, 2019 | Initial | $31,124,999 | No comparison | 3 | SEC filing |
| Sep 13, 2019 | Initial | $25,000,002 | No comparison | 1 | SEC filing |
| Nov 9, 2017 | Initial | $50,000,000 | No comparison | 1 | SEC filing |
| Aug 16, 2016 | Initial | $12,000,000 | No comparison | 1 | SEC filing |
| Jun 17, 2015 | Initial | $0 | No comparison | 3 | SEC filing |
| Jun 28, 2013 | Amendment | $13,500,000 | $0vs Jun 27, 2013 | 5 | SEC filing |
| Jun 27, 2013 | Initial | $13,500,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-365363
Source: Form D, filed Apr 27, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sumit Aggarwal | Executive |
| Jeffrey Alter | Director |
| John Bigalke | Director |
| Eric D'esparbes | Executive |
| Jeffrey Ferrell | Director |
| Eric Fox | Executive |
| Paul Hawran | Promoter |
| Brian Kotzin | Director |
| Clarke Neumann | Executive |
| Samuel Nussbaum | Director |
| Lynne Powell | Director |
| Howard Slutsky | Director |
| Harry Stylli | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:San Diego, CA, 92122